IMMU-48. GLIOMA IMMUNE PROFILING REVEALS UNIQUE IMMUNE THERAPEUTIC OPPORTUNITIES

INTRODUCTION: There is a rapidly evolving portfolio of immune therapeutic modulators, but the relative incidence of immune targets in human gliomas is unknown. To prioritize available immune therapeutics, comprehensive immune profiling across glioma grades was conducted. METHODS: CD4+ and CD8+ T-cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Ott, Martina, Zhou, Shouhao, Wei, Jun, de Groot, John, Huse, Jason T, McCutcheon, Ian, Prabhu, Sujit, Ferguson, Sherise, Weinberg, Jeffrey, Sawaya, Raymond, Rao, Ganesh, Lang, Frederick, Heimberger, Amy
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216472/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.551
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares